» Articles » PMID: 36963517

Weight Changes in Adults with Major Depressive Disorder: A Systematic Review and Meta-analysis of Prospective Studies

Overview
Journal J Affect Disord
Date 2023 Mar 24
PMID 36963517
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Major Depressive Disorder (MDD) and obesity are bidirectionally related, but the amount of weight-gain secondary to MDD is unknown. We aimed to estimate the adjusted effect of MDD on weight-change in prospective studies compared to individuals without MDD.

Methods: Scopus/MEDLINE, PsycInfo, Web of Science and Cochrane were systematically searched for prospective observational studies of participants with a diagnosis of MDD. We included studies that conducted regression analyses on weight-variables. We searched for weight-variables reported at baseline, follow-up, and regression analyses. A meta-analysis of the odds ratios reported in logistic regression models was performed using the generic inverse weight variance method.

Results: Eight studies were included with a total of 60,443 subjects; 56.8 % with MDD. Weight-variables included weight, BMI, waist circumference, fat mass, and obesity incidence. In three follow-up reports, weight-variables increased more in participants with MDD and its subphenotypes than in control subjects, except for one MDD subphenotype. Meta-analysis of three eligible studies (n = 21,935) showed a significantly greater likelihood of incident obesity in participants with MDD (OR:1.48, 95%CI 1.03-2.13). MDD subphenotype reports might suggest a greater risk for atypical MDD.

Limitations: Heterogeneity in weight related variables, follow-ups, and regression models; scarcity of follow-up data; and limited studies eligible for meta-analysis.

Conclusions: Despite previous associations between MDD and obesity, current prospective evidence on MDD related weight-change is scarce and heterogeneous. Our findings suggest a need to standardize weight-change assessment in MDD trials. Moreover, careful weight tracking and management should be incorporated in clinical settings. PROSPERO registration CRD42020214427.

Citing Articles

Clinical features of overweight in acute-phase hospitalised major depressive disorder with comorbid anxiety: a cross-sectional study.

Zhang H, Ma J, Wang J, Zhu W, Liu X BMJ Open. 2025; 15(2):e087640.

PMID: 39987012 PMC: 11848675. DOI: 10.1136/bmjopen-2024-087640.


Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications.

Moss L, Laudenslager M, Steffen K, Sockalingam S, Coughlin J Curr Obes Rep. 2025; 14(1):2.

PMID: 39753939 DOI: 10.1007/s13679-024-00598-5.


The relationship between BMI and depression: a cross-sectional study.

Cui H, Xiong Y, Wang C, Ye J, Zhao W Front Psychiatry. 2024; 15:1410782.

PMID: 39502295 PMC: 11534730. DOI: 10.3389/fpsyt.2024.1410782.


The Absence of Items Addressing Increased Appetite or Weight in Depressive-Symptom Questionnaires: Implications for Understanding the Link between Major Depressive Disorder, Antidepressants, and Obesity.

Trevino-Alvarez A, Gluck M, McElroy S, Cuellar-Barboza A Brain Sci. 2024; 14(8).

PMID: 39199532 PMC: 11352823. DOI: 10.3390/brainsci14080841.


Atherogenic Index of Plasma as a Mediator in the association between Body Roundness Index and Depression: insights from NHANES 2005-2018.

Zhang G, Zhang H, Fu J, Zhao Y Lipids Health Dis. 2024; 23(1):183.

PMID: 38867232 PMC: 11167922. DOI: 10.1186/s12944-024-02177-y.